Dr. Macy Osborne-Frazier brings extensive expertise in oncology, immunology, women’s health, and biomarker research to her role at Phoenix Rising Communications. She earned her PhD in Pathobiology and Translational Science from the University of North Carolina at Chapel Hill, where she investigated the molecular mechanisms of immune evasion in endometrial cancer using cellular models, patient tumor samples, and large-scale bioinformatic analyses.

Dr. Osborne-Frazier’s background in translational and molecular oncology enables her to craft scientifically rigorous and clinically relevant communications that bridge discovery and patient impact.

Learn more about how Dr. Osborne-Frazier brings scientific expertise to every collaboration.